CAIMH
CLBT icon

Central Asset Investments & Management Holdings’s Cellebrite CLBT Stock Holding History

Central Asset Investments & Management Holdings’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,463
Closed -$182K – 56
2024
Q1 		$182K Buy
16,463
+3,463
+27% +$35.3K 0.15% 43
2023
Q4 		$113K Buy
+13,000
New +$101K 0.11% 41

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
CC
Crosslink Capital Menlo Park, California $1.02B AUM 9.21% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Central Asset Investments & Management Holdings's CLBT Position: Q2 2024 in Review

Central Asset Investments & Management Holdings sold out of Cellebrite (CLBT) in Q2 2024, closing a stake of 16,463 shares — an estimated $182K sold.

Central Asset Investments & Management Holdings first reported a position in CLBT in Q4 2023 and held it in 2 quarters. The position peaked at $182K in Q1 2024. 148 funds tracked by Wall St. Rank hold CLBT as of Q2 2024.

  • Central Asset Investments & Management Holdings reported no remaining Cellebrite position as of Q2 2024 after selling out during the quarter.
  • Central Asset Investments & Management Holdings sold 16,463 Cellebrite shares in Q2 2024, an estimated $182K.
  • Central Asset Investments & Management Holdings first reported a position in Cellebrite in Q4 2023 and held it in 2 quarters.
  • Central Asset Investments & Management Holdings's Cellebrite position peaked at $182K in Q1 2024.
  • 148 funds tracked by Wall St. Rank held Cellebrite as of Q2 2024.

Based on Central Asset Investments & Management Holdings's 13F filing for Q2 2024, filed 12 Aug 2024.